Cargando…
Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study
Clopidogrel is the mainstay for antiplatelet treatment after percutaneous coronary intervention (PCI). The relationship of platelet reactivity and genetic polymorphism with clinical outcomes with newer-generation drug-eluting stents is unclear. We analysed 4,587 patients for the most powerful single...
Autores principales: | Joo, Hyung Joon, Ahn, Sung Gyun, Park, Jae Hyoung, Park, Ji Young, Hong, Soon Jun, Kim, Seok-Yeon, Choi, WoongGil, Gwon, HyeonCheol, Lim, Young-Hyo, Kim, Weon, Kang, Woong Chol, Cho, Yun-Hyeong, Kim, Yong Hoon, Yoon, JungHan, Shin, WonYong, Hong, Myeong-Ki, Garg, Scot, Jang, Yangsoo, Lim, Do-Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775197/ https://www.ncbi.nlm.nih.gov/pubmed/29352151 http://dx.doi.org/10.1038/s41598-017-18134-y |
Ejemplares similares
-
Impact of genetic variants on major bleeding after percutaneous coronary intervention based on a prospective multicenter registry
por: Cha, Jung-Joon, et al.
Publicado: (2021) -
Impact of genetic variants on clinical outcome after percutaneous coronary intervention in elderly patients
por: Cha, Jung-Joon, et al.
Publicado: (2021) -
Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial
por: Lee, Seung-Jun, et al.
Publicado: (2023) -
Comparison of Full Lesion Coverage versus Spot Drug-Eluting Stent Implantation for Coronary Artery Stenoses
por: Kim, Seunghwan, et al.
Publicado: (2014) -
Optimal duration of DAPT after second-generation drug-eluting stent in acute coronary syndrome
por: Jang, Ji-Yong, et al.
Publicado: (2018)